Antiviral therapy reduces HRQOL in patients with hepatitis C

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1100, 2006-01, pp. : 5-5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bezafibrate therapy reduces serum hepatitis C virus (HCV) RNA titre in patients with chronic HCV infection

By  

Inpharma, Vol. 1, Iss. 1469, 2005-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Recent Advances in Pegylated Interferon Antiviral Therapy of Chronic Hepatitis C

By  

Anti-Infective Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Infective Agents), Vol. 5, Iss. 4, 2006-10 ,pp. : 379-387

Bentham Science Publishers

Access to resources Recommend Favorite

Mechanisms Involved in the Development of Chronic Hepatitis C as Potential Targets of Antiviral Therapy

By  

Current Pharmaceutical Biotechnology, Vol. 12, Iss. 11, 2011-11 ,pp. : 1774-1780

Bentham Science Publishers

Access to resources Recommend Favorite

Hepatitis C virus: quasispecies dynamics, virus persistance and antiviral therapy

By Cristina Juan  

Expert Opinion on Therapeutic Patents, Vol. 17, Iss. 5, 2007-05 ,pp. : 499-510

Informa Healthcare

Access to resources Recommend Favorite

Helicase inhibitors as specifically targeted antiviral therapy for hepatitis C

By Belon Craig A   Frick David N  

Future Virology, Vol. 4, Iss. 3, 2009-05 ,pp. : 277-293

Future Medicine

Access to resources Recommend Favorite